Neoadjuvant cisplatin,methotrexate,and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial

Griffiths Gareth

doi:10.1016/s0140-6736(99)02292-8

Keywords

MedicineCystectomyVinblastineChemotherapyTransitional cell carcinomaBladder cancerRadiation therapyCisplatinSurgeryOncologyInternal medicineUrologyCancer

Related Publications

Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial. International collaboration of trialists.

Three cycles of neoadjuvant chemotherapy before cystectomy or radiotherapy did not give the 10% improvement in 3-year survival that was judged to be necessary for introduction i...

1999 PubMed 162 citations

European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)

Marko Babjuk , Maximilian Burger , Otakar Čapoun +14 more

The European Association of Urology (EAU) has released an updated version of the guidelines on non-muscle-invasive bladder cancer (NMIBC). To present the 2021 EAU guidelines on ...

2021 European Urology 1420 citations

European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines

J. Alfred Witjes , Harman Max Bruins , Richard Cathomas +12 more

This overview presents the updated European Association of Urology (EAU) guidelines for muscle-invasive and metastatic bladder cancer (MMIBC). To provide practical evidence-base...

2020 European Urology 2051 citations

Bladder Cancer

Andrew T. Lenis , Patrick M. Lec , Karim Chamie +1 more

Improved understanding of the molecular biology and genetics of bladder cancer has evolved the way localized and advanced disease is diagnosed and treated. While intravesical BC...

2020 JAMA 1621 citations

Treatment of muscle‐invasive and advanced bladder cancer in 2020

Vaibhav G. Patel , William Oh , Matthew D. Galsky

Abstract Bladder cancer accounts for nearly 170,000 deaths worldwide annually. For over 4 decades, the systemic management of muscle‐invasive and advanced bladder cancer has pri...

2020 CA A Cancer Journal for Clinicians 1092 citations

Publication Info

Year: 1999
Type: article
Volume: 354
Issue: 9178
Pages: 533-540
Citations: 492
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Neoadjuvant cisplatin,methotrexate,and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

492

OpenAlex

Cite This

APA Style

                            
                                    Griffiths Gareth
                                
                            (1999). 
                            Neoadjuvant cisplatin,methotrexate,and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial. 
                            The Lancet
                            , 354
                            (9178)
                            , 533-540.
                            https://doi.org/10.1016/s0140-6736(99)02292-8

Identifiers

DOI: 10.1016/s0140-6736(99)02292-8